BioTech
The rare pediatric disease voucher program creates new treatments. I have new data to prove it
The Food and Drug Administration’s rare pediatric disease priority review voucher program, which has been providing incentives for lifesaving innovations since 2012, is doomed to
Pamela K. Gavin
July 2, 2024